UNSPSC 51101653: Fumagillin

This classification denotes an antineoplastic antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7OW73204U1. European Medicines Agency schedules Fumagillin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB23269. Fumagillin generally arises in the molecular formula C26H34O7. The term FUMAGILLIN is an International Non-Proprietary Name or INN. FUMAGILLIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix.

Most nations schedule fumagillin under HS 29419000 and SITC 54139. As of Q4 2014, FUMAGILLIN remains the US FDA Preferred Term for this commodity. Fumagillin bears US NLM identifiers UMLS ID C0060819 and NCI Concept Code C75963. SMILES: O1C(C2C3(OC3)CCC(OC(=O)/C=C/C=C/C=C/C=C/C(=O)O)C2OC)(C1C/C=C(/C)C)C.

UNSPSC 51101653 Fumagillin is a Commodity code intended to capture procurement of the antimicrobial agent fumagillin; however, the recent state and local opportunities tagged under this code show no activity aligned with fumagillin itself. Instead, the two posted records reflect pharmaceutical and medical-supply procurement of unrelated products—doxycycline hyclate, ciprofloxacin hydrochloride, and naloxone—suggesting either systematic miscoding or a data-quality issue in how opportunities are tagged to this Commodity. State and local health departments and counties are the primary issuing bodies appearing in the record, using piggyback cooperative purchasing agreements and competitive sealed bids to acquire pharmaceuticals and emergency medical supplies for community health and public health emergency preparedness. The work involves warehouse supply contracts with defined unit volumes, expiration specifications, and quarterly or as-needed delivery schedules.

Recent activity appears limited and geographically scattered. The Illinois Department of Public Health awarded a $2.99 million piggyback pharmaceutical warehouse contract to Chartwell Rx LLC through the MMCAP Infuse consortium in August 2026 (Solicitation 26482DPHPREPDB53392, closed award, not an open opportunity). Seminole County, Florida issued an IFB in June 2026 (IFB60459723LAS) seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually, due July 26, 2026, with quarterly deliveries to the county's community health building. No open solicitations under this code are currently active. The mismatch between the code's nominal scope and the actual products being procured suggests that firms pursuing pharmaceutical supply work should verify code alignment before bid-strategy decisions.